Epalrestat
Epalrestat CAS No .: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Tha epalrestat air a chleachdadh gus casg, ameliorate, agus làimhseachadh neuropathy peripheral (numbness, pian), paresthesia vibrational, agus ana-cainnt cridhe co-cheangailte ri tinneas an t-siùcair. SÒNRACHADH
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Tha epalrestat air a chleachdadh gus casg, ameliorate, agus làimhseachadh neuropathy peripheral (numbness, pian), paresthesia vibrational, agus ana-cainnt cridhe co-cheangailte ri tinneas an t-siùcair. SÒNRACHADH
D roduct ainm | Epalrestat |
CAS | 82159-09-9 |
MF: | C15H13NO3S2 |
MW: | 319.4 |
Sgrìobh do theachdaireachd an seo agus cuir thugainn e